For the quarter ending 2026-03-31, SPRB had $5,174K increase in cash & cash equivalents over the period. -$8,742K in free cash flow.
| Cash Flow | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 |
|---|---|---|---|---|
| Net loss | -12,266 | -14,646 | -24,320 | - |
| Stock-based compensation expense | 689 | 1,692 | 882 | - |
| Depreciation and amortization | 252 | 5 | 16 | - |
| Non-cash lease expense | 71 | 69 | 199 | - |
| Loss on disposal of property and equipment | - | 0 | 0 | - |
| Change in fair value of warrant and conversion option liabilities | 91 | 4,017 | -517 | - |
| Prepaid expenses and other current assets | -2,054 | -841 | -1,606 | - |
| Other assets | -64 | 0 | 0 | - |
| Accounts payable | 1,700 | -443 | 91 | - |
| Accrued expenses and other current liabilities | -1,300 | 1,808 | -4,310 | - |
| Deferred revenue | - | 0 | 0 | - |
| Other liabilities | -87 | 201 | -518 | - |
| Net cash used in operating activities | -8,732 | -6,456 | -26,871 | - |
| Proceeds from exercise of pre-funded warrants | - | 40 | - | - |
| Purchases of property and equipment | 10 | - | - | - |
| Proceeds from exercise of common stock options | - | 5 | 0 | - |
| Proceeds from issuance of common stock and warrants | - | 50,000 | - | - |
| Net cash used in investing activities | -10 | - | - | - |
| Proceeds from issuance of common stock related to employee stock purchase plan | - | 22 | 3 | - |
| Proceeds from debt, gross | 14,146 | - | - | - |
| Repayment of debt | 0 | 841 | 1,216 | - |
| Payment of debt and equity offering costs | 220 | 3,701 | - | - |
| Tax withholding payments on restricted stock units | 10 | 831 | 0 | - |
| Net cash provided by (used in) financing activities | 13,916 | 44,694 | -1,213 | - |
| Restricted cash | - | - | - | 35 |
| Net increase (decrease) in cash, cash equivalents, and restricted cash | 5,174 | 38,238 | -28,084 | - |
| Cash and cash equivalents, at carrying value, ending balance | - | - | - | 16,387 |
| Cash, cash equivalents, and restricted cash at beginning of period | 48,942 | 10,704 | 16,422 | - |
| Cash, cash equivalents, and restricted cash at end of period | 54,116 | 48,942 | 10,704 | 16,422 |
SPRUCE BIOSCIENCES, INC. (SPRB)
SPRUCE BIOSCIENCES, INC. (SPRB)